| 摘要 |
<p>An abnormal keratinization skin disease diagnosis kit is provided to diagnose rapidly abnormal keratinization skin disease and to screen a keratinocyte allotypic differentiation antisagging agent. An abnormal keratinization skin disease diagnosis kit comprises specific polynucleotide or polynucleotide thereof and a solid support. The specific polynucleotide is one or more selected from a group consisting of SEC24D, WASF1, MTFR1, STT3A, CDKN3, EIF2B3, PTPRZ1, TRIM37, GTF2H2, ATM, FST, G3BP2, TETRAN, MDFIC, ALG14, RPS7, OLFM1, RCN2, IGSF3, HS3ST1, ERLIN1, IL1A, SST, FHL1, PTGS2, BCAT1, DNAJC10, IBTK, ODC1, OR7E38P, TIMM17A, PLDN, TBPL1, PFAS, TTTY15, FAM91A1, SNRPG, SNRPB2, SLMO2, SCFD1, ATP11C, CYCS, CD9, CKS1B, DPM1, UQCRQ, CPSF2, RNF41, PDE4D, HLA-DOB, CSNK1G3, LYSMD3, DORA2B, SSR1, GALK2, GTF2H3, ZNF410, TXNL2, NUS1, MEF2B, GPD2, AMMECR1L, SLC3A2, MAD2L2, MGAT1, ATP5E, FXN, TAF7, DCK, NCOA1, AKAP8L, CA14, CRSP8, C7orf30, FAM126A, SEC23B, CTBS, BBS12, TRIM32, RAE1, PBEF1, TNFAIP8, C10orf104, PPP2R1B, RNF139, PRDX6, CBX5, ARG2, HOXD8 and C10orf11.</p> |
